Affordable Access

Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma

Authors
  • Chapman, Owen S
  • Luebeck, Jens
  • Sridhar, Sunita
  • Wong, Ivy Tsz-Lo
  • Dixit, Deobrat
  • Wang, Shanqing
  • Prasad, Gino
  • Rajkumar, Utkrisht
  • Pagadala, Meghana S
  • Larson, Jon D
  • He, Britney Jiayu
  • Hung, King L
  • Lange, Joshua T
  • Dehkordi, Siavash R
  • Chandran, Sahaana
  • Adam, Miriam
  • Morgan, Ling
  • Wani, Sameena
  • Tiwari, Ashutosh
  • Guccione, Caitlin
  • And 28 more
Publication Date
Dec 01, 2023
Source
eScholarship - University of California
Keywords
License
Unknown
External links

Abstract

Circular extrachromosomal DNA (ecDNA) in patient tumors is an important driver of oncogenic gene expression, evolution of drug resistance and poor patient outcomes. Applying computational methods for the detection and reconstruction of ecDNA across a retrospective cohort of 481 medulloblastoma tumors from 465 patients, we identify circular ecDNA in 82 patients (18%). Patients with ecDNA-positive medulloblastoma were more than twice as likely to relapse and three times as likely to die within 5 years of diagnosis. A subset of tumors harbored multiple ecDNA lineages, each containing distinct amplified oncogenes. Multimodal sequencing, imaging and CRISPR inhibition experiments in medulloblastoma models reveal intratumoral heterogeneity of ecDNA copy number per cell and frequent putative 'enhancer rewiring' events on ecDNA. This study reveals the frequency and diversity of ecDNA in medulloblastoma, stratified into molecular subgroups, and suggests copy number heterogeneity and enhancer rewiring as oncogenic features of ecDNA.

Report this publication

Statistics

Seen <100 times